Oral Vinorelbine and Cisplatin as Induction Chemotherapy and Concomitant Chemo-Radiotherapy in Stage III Non-small Cell Lung Cancer: Final Results of an International Phase II Trial-Reference-Cited by-同舟云学术

Oral Vinorelbine and Cisplatin as Induction Chemotherapy and Concomitant Chemo-Radiotherapy in Stage III Non-small Cell Lung Cancer: Final Results of an International Phase II Trial

Published:2008-09 Issue:9 Volume:3 Page:994-1002
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Krzakowski Maciej,Provencio Mariano,Utracka-Hutka Beata,Villa Eugenio,Codes Manuel,Kuten Abraham,Henke Michael,Lopez Massimo,Bell David,Biti Giampaolo,Merimsky Ofer,Beorchia Aulo,Riggi Marcello,Caux Noël-Raphaël,Pouget Jean-Christophe,Dubray Bernard,David Philippe

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference41 articles.

1. Epidemiology of lung cancer: looking to the future;Alberg;J. Clin Oncol,2005

2. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIA and IIIb non-small cell lung cancer: a meta-analysis;Pignon;Cancer,1996

3. Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B non small cell lung carcinoma: a modified Phase I trial;Socinski;Cancer,2000

4. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer;Rosell;N Engl J Med,1994

5. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer;Roth;J Natl Cancer Inst,1994

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis;eClinicalMedicine;2023-10

2. Gender is a non-negligible risk factor affecting the overall survival time of NSCLC patients: a nationwide population-based study;2023-01-31

3. Vinorelbine in treatment of non-small cell lung cancer;Medical alphabet;2021-06-28

4. Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03);Therapeutic Advances in Medical Oncology;2021-01

5. Oral Chemotherapy for Treatment of Lung Cancer;Frontiers in Oncology;2020-04-28